Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischemic events after percutaneous coronary intervention: A sub-study of the TWILIGHT trial.
Baber U, Cao D, Collier T, Sartori S, Dangas G, Angiolillo DJ, Vogel B, Kunadian V, Briguori C, Cohen DJ, Dudek D, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Mehta S, Moliterno DJ, Ohman EM, Escaned J, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Steg PG, Pocock S, Mehran R.
Baber U, et al. Among authors: mehran r.
Eur Heart J Cardiovasc Pharmacother. 2024 Oct 17:pvae080. doi: 10.1093/ehjcvp/pvae080. Online ahead of print.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 39419783